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Asparagine synthetase deficiency (ASNSD, MIM 615574) is a
recently delineated rare neurometabolic disorder caused by
mutations in ASNS (MIM 108370) (Ruzzo et al. 2013). It is
characterized by congenital and/or postnatal progressive micro-
cephaly, global developmental delay, seizures, growth retarda-
tion, cerebral atrophy, and simplified gyral pattern. We hereby
describe four novel variations ascertained by exome sequencing
in three individuals from three unrelated families (Fig. S1, Sup-
porting information). We summarize the genotype and pheno-
type of 22 individuals from 14 families with 16 mutations in
ASNS (Ruzzo et al. 2013; Alfadhel et al. 2015; Ben-Salem
et al. 2015; Palmer et al. 2015; Gataullina et al. 2016;
Seidahmed et al. 2016; Gupta et al. 2017; Sun et al. 2017;
Yamamoto et al. 2017). Informed consents from the families
were obtained for the study. The study was approved by the
Institutional Ethics Committee. Detailed clinical information,
exome sequencing methodology, and analysis are provided in
Appendix S1.
All three individuals showed congenital microcephaly, progres-
sive postnatal microcephaly, and spasticity, whereas seizures were
noted only in patients 1 and 3 (Table S1). Magnetic resonance
imaging of brain revealed simplified gyral pattern, cerebral atro-
phy, and pontocerebellar hypoplasia in all patients (Fig. 1). Whole
exome sequencing (WES) analysis in patient 1 revealed a novel
homozygous missense variant, c.1211G>A [p.(Arg404His)], in
exon 10 of ASNS gene. Analysis of patient 2 disclosed novel com-
pound heterozygous variants, c.224A>G [p.(Asn75Ser)] in exon
3 and c.413A>C [p.(Asp138Ala)] in exon 4 of ASNS gene. In
patient 3, a novel homozygous variant, c.1649G>A [p.
(Arg550His)], was observed. These variants are not present in
either homozygous or heterozygous states in databases of normal
population. These variants are also not observed in our in-house
database of 357 families. These variants occur at a highly con-
served region and predicted as damaging to ASNS protein func-
tion. Further analysis by in silico or any other functional assay
could not be performed for these variants.
A review of 25 individuals including our patients revealed
significant global developmental delay (22/23) in most individ-
uals. Congenital microcephaly and simplified gyral pattern on
brain imaging was evident in a significant proportion (19/25) of
individuals. Other frequent brain imaging findings were ponto-
cerebellar hypoplasia/reduced pons size (16/25) and progressive
cerebral atrophy seen in all the individuals. Spastic quadrapar-
esis (19/24) and seizures (18/25) are the other common findings
in individuals with ASNSD (Table S1). High degree of inbreed-
ing observed in the local population is the possible cause of
homozygous variants in non-consanguineous families in our
study.
We herein emphasize the utility of whole exome sequencing as
an important tool in delineating the genetic etiology in individ-
uals with rare and clinically heterogeneous phenotypes. We also
add four novel mutations, thus expanding the ASNS mutation
spectrum. The presence of variable degree of congenital micro-
cephaly underscores that this condition should be considered
among the various genetic disorders presenting with primary
microcephaly.
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SUPPORTING INFORMATION
Additional supporting information may be found online in the
supporting information tab for this article.
Appendix S1. Details of clinical data and exome sequencing.
Fig. S1. Family pedigrees and mutations in the three families with
asparagine synthetase deficiency (A–C). Patient 2 is a compound
heterozygous for ASNS variation where father is heterozygous for
c.413A>C and mother is heterozygous for c.224A>G variant in
ASNS (B).
Table S1. Phenotype and genotype information of individuals in
the present study and previously reported 22 individuals.
Fig. 1 (A) Brain magnetic resonance
imaging (MRI) of patient 1 taken
on day 2 of life. Axial T1- (i), axial
T2- (ii), and sagittal T1 (iii)-
weighted images show
microcephaly with overlapping of
sutures, simplified gyral pattern,
delayed myelination, reduced
volume of the pons, and mild
cerebral atrophy. (B) Brain MRI
images of patient 2 taken at
1 month of age. Axial T1- (i), axial
T2- (ii) and sagittal T2 (iii)-
weighted images show
microcephaly with overlapping
sutures, mild delayed myelination,
reduced size of the pons, and
cerebral atrophy. (C) Brain MRI
images of patient 3 on day 2 of life.
Axial T1- (i), coronal T2- (ii) and
sagittal T1 (iii)-weighted images
show microcephaly with
overlapping of sutures, simplified
gyral pattern, reduced volume of
the pons, and cerebral atrophy.
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